Humacyte, Inc.HUMANASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
54.17%
↑ 303% above average
Average (23q)
-26.71%
Historical baseline
Range
High:325.00%
Low:-561.54%
Volatility
-3318.6%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 54.17% |
| Q2 2025 | -185.71% |
| Q1 2025 | 275.00% |
| Q4 2024 | 51.52% |
| Q3 2024 | 31.25% |
| Q2 2024 | -65.52% |
| Q1 2024 | -20.83% |
| Q4 2023 | 4.00% |
| Q3 2023 | -13.64% |
| Q2 2023 | 63.33% |
| Q1 2023 | -561.54% |
| Q4 2022 | 152.00% |
| Q3 2022 | -169.44% |
| Q2 2022 | 325.00% |
| Q1 2022 | -139.02% |
| Q4 2021 | 156.94% |
| Q3 2021 | -323.53% |
| Q2 2021 | 15.00% |
| Q1 2021 | 96.43% |
| Q4 2020 | -292.31% |
| Q3 2020 | -110.29% |
| Q2 2020 | 16.05% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |